{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:05Z","timestamp":1793214605272,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.preteyeres.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T09:56:36Z","timestamp":1361872596000},"page":"44-62","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Scleritis: Immunopathogenesis and molecular basis for therapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Denis","family":"Wakefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Thurau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhild","family":"Wildner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2013.02.004_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.30236","article-title":"B\u00a0cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjogren's syndrome: a double-blind, placebo-controlled study","volume":"63","author":"Abdulahad","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/ard.2004.027128","article-title":"Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab","volume":"64","author":"Ahmadi-Simab","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10384-008-0652-5","article-title":"Treating refractory scleritis with infliximab","volume":"53","author":"Ahn","year":"2009","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2010.24.6.331","article-title":"Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population","volume":"24","author":"Ahn","year":"2010","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib5","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar2689","article-title":"Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis","volume":"11","author":"Akhavani","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ancard.2012.04.009","article-title":"Increased cardiovascular risk and premature atherosclerosis in rheumatoid arthritis","volume":"61","author":"Akrout","year":"2012","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib8","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.ophtha.2005.05.008","article-title":"Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis","volume":"112","author":"Albini","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.iio.0000155900.64809.b2","article-title":"The diagnosis and management of anterior scleritis","volume":"45","author":"Albini","year":"2005","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/rheumatology\/keh635","article-title":"Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy","volume":"44","author":"Ashok","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.rhu.0000249766.24780.95","article-title":"Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab","volume":"12","author":"Atchia","year":"2006","journal-title":"J.\u00a0Clin. Rheumatol."},{"issue":"Suppl. 3","key":"10.1016\/j.preteyeres.2013.02.004_bib13","doi-asserted-by":"crossref","first-page":"iii56","DOI":"10.1136\/ard.2007.078360","article-title":"Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility","volume":"66","author":"Bakker","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0039-6257(88)90093-8","article-title":"Posterior scleritis","volume":"32","author":"Benson","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.06.025","article-title":"Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized clinical entity","volume":"148","author":"Bhat","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib17","first-page":"195","article-title":"Posterior scleritis: clinical profile and imaging characteristics","volume":"46","author":"Biswas","year":"1998","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1994.149","article-title":"Neutrophil activation in\u00a0vitro and in\u00a0vivo in Wegener's granulomatosis","volume":"45","author":"Brouwer","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-4362.1996.tb03273.x","article-title":"Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection","volume":"35","author":"Buezo","year":"1996","journal-title":"Int. J. Dermatol."},{"issue":"Pt 3","key":"10.1016\/j.preteyeres.2013.02.004_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/eye.1988.52","article-title":"Posterior scleritis: a clinical and histological survey","volume":"2","author":"Calthorpe","year":"1988","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/ajkd.2003.50130","article-title":"Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia","volume":"41","author":"Carroll","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.eye.6701457","article-title":"The successful use of infliximab in resistant relapsing polychondritis and associated scleritis","volume":"19","author":"Cazabon","year":"2005","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/bjo.2008.147157","article-title":"Rituximab for treatment of scleritis associated with rheumatoid arthritis","volume":"93","author":"Chauhan","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.075689","article-title":"Successful treatment of Wegener's granulomatosis associated scleritis with rituximab","volume":"89","author":"Cheung","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib25","first-page":"1","article-title":"Hepatitis B virus (HBV) and systemic vasculitis","volume":"9","author":"Christian","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib26","first-page":"2597","article-title":"Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group","volume":"27","author":"Clarke","year":"2000","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1523-1755.1999.055003852.x","article-title":"Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"55","author":"Cockwell","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib28","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/1529-0131(199912)42:12<2569::AID-ANR9>3.0.CO;2-3","article-title":"Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis","volume":"42","author":"Cook","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jcjo.2011.06.009","article-title":"Adjunctive globe magnetic resonance imaging in the diagnosis of posterior scleritis","volume":"46","author":"Cordero-Coma","year":"2011","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib31","doi-asserted-by":"crossref","first-page":"73ps9","DOI":"10.1126\/scitranslmed.3002138","article-title":"Dissecting the immune cell mayhem that drives lupus pathogenesis","volume":"3","author":"Craft","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/ICO.0b013e31820967bd","article-title":"Management and outcome of microbial anterior scleritis","volume":"30","author":"Cunningham","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib34","first-page":"653","article-title":"Increased expression of matrix metalloproteinases in\u00a0vivo in scleritis tissue and in\u00a0vitro in cultured human scleral fibroblasts","volume":"150","author":"Di Girolamo","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jlb.61.6.667","article-title":"Expression of TNF-alpha by human plasma cells in chronic inflammation","volume":"61","author":"Di Girolamo","year":"1997","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B","article-title":"Expression of matrix metalloproteinases by human plasma cells and B lymphocytes","volume":"28","author":"Di Girolamo","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","article-title":"Infliximab for the treatment of refractory scleritis","volume":"94","author":"Doctor","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/ar603","article-title":"Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjogren's syndrome","volume":"4","author":"Dorner","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib39","first-page":"S22","article-title":"Disease activity measures for rheumatoid arthritis","volume":"25","author":"Dougados","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib40","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1167\/iovs.04-0496","article-title":"Interaction of lumican with aggrecan in the aging human sclera","volume":"45","author":"Dunlevy","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2567.1999.00772.x","article-title":"Do self-perpetuating B lymphocytes drive human autoimmune disease?","volume":"97","author":"Edwards","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib42","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0167-5699(97)01118-3","article-title":"strategies to restrain this proinflammatory cytokine","volume":"18","author":"Eigler","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.eye.6701712","article-title":"Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis","volume":"19","author":"El-Shabrawi","year":"2005","journal-title":"Eye (Lond.)"},{"issue":"11","key":"10.1016\/j.preteyeres.2013.02.004_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/jir.2011.0045","article-title":"Type I interferon and systemic lupus erythematosus","volume":"31","author":"Elkon","year":"2011","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cca.2005.09.020","article-title":"Review: collagen markers in early arthritic diseases","volume":"365","author":"Elsaid","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICO.0b013e3181ac9fad","article-title":"Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey","volume":"29","author":"Erkanli","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/ar380","article-title":"Collagen of articular cartilage","volume":"4","author":"Eyre","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib49","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in\u00a0vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(91)32280-2","article-title":"Immunopathology of scleritis","volume":"98","author":"Fong","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1096\/fj.08-110213","article-title":"Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils","volume":"23","author":"Fortin","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bjo.60.3.227","article-title":"Evaluation of eyes enucleated for scleritis","volume":"60","author":"Fraunfelder","year":"1976","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/IAE.0b013e318191df82","article-title":"Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume":"29","author":"Fraunfelder","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","article-title":"Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation","volume":"113","author":"Galor","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib55","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ophtha.2007.03.018","article-title":"Rheumatic disease and scleritis","volume":"114","author":"Galor","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib56","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib58","article-title":"Canine episcleritis, nodular episclerokeratitis, scleritis, and necrotic scleritis","volume":"38","author":"Grahn","year":"2008","journal-title":"Vet. Clin. North America Small Anim. Pract."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-6420(85)33822-8","article-title":"Necrotizing scleritis due to varicella zoster infection: a case report","volume":"14","author":"Gungor","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(96)00111-1","article-title":"Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays","volume":"196","author":"Hagen","year":"1996","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(91)32280-2","article-title":"Systemic associations of scleritis","volume":"33","author":"Hakin","year":"1991","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib63","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1523-1755.2001.0590051729.x","article-title":"Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis","volume":"59","author":"Harper","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/archopht.116.11.1476","article-title":"Modulation of HLA antigen expression on conjunctival fibroblasts by gamma-interferon","volume":"31","author":"Harrison","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib65","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1016\/S0021-9258(19)74250-1","article-title":"Binding of fibromodulin and decorin to separate sites on fibrillar collagens","volume":"268","author":"Hedbom","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar3236","article-title":"In\u00a0vivo approaches to investigate ANCA-associated vasculitis: lessons and limitations","volume":"13","author":"Heeringa","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib67","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bjo.2006.102046","article-title":"Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and haematopoietic stem cell transplantation","volume":"91","author":"Hisatomi","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archopht.126.5.651","article-title":"Antineutrophil cytoplasmic antibody-associated active scleritis","volume":"126","author":"Hoang","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib69","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaut.2009.02.019","article-title":"ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy","volume":"32","author":"Holle","year":"2009","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9394(81)90001-5","article-title":"Targeting Toll-like receptors for treatment of SLE","author":"Horton","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib72","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.autrev.2011.04.004","article-title":"Dysregulated neutrophil\u2013endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention","volume":"10","author":"Hu","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib73","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/ard.2005.046367","article-title":"Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany","volume":"65","author":"Huscher","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2012.06.035","article-title":"Regional corticosteroids for scleritis","volume":"119","author":"Jabs","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib75","first-page":"1223","article-title":"Ocular inflammation in autoimmune MRL\/Mp mice","volume":"26","author":"Jabs","year":"1985","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3899\/jrheum.110901","article-title":"Socioeconomic burden of immune-mediated inflammatory diseases \u2013 focusing on work productivity and disability","volume":"88","author":"Jacobs","year":"2011","journal-title":"J.\u00a0Rheumatol. Suppl."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MNH.0b013e3283456731","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis","volume":"20","author":"Jennette","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2009.07.035","article-title":"Evaluation of sub-Tenon triamcinolone acetonide injections in the treatment of scleritis","volume":"149","author":"Johnson","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2007.079095","article-title":"Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response","volume":"67","author":"Jonsdottir","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/17453679209154825","article-title":"Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13,000","volume":"63","author":"Jonsson","year":"1992","journal-title":"Acta Orthop. Scand."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib84","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.ophtha.2011.06.009","article-title":"Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective","volume":"118","author":"Joshi","year":"2011","journal-title":"Ophthalmology"},{"issue":"Suppl. 1","key":"10.1016\/j.preteyeres.2013.02.004_bib85","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1136\/ard.2010.138024","article-title":"Pathogenesis of ANCA-associated vasculitides","volume":"70","author":"Kallenberg","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.autrev.2008.07.020","article-title":"Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to \u201cautoimmunity and infection\u201d","volume":"8","author":"Kallenberg","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib87","first-page":"253","article-title":"Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis","volume":"13","author":"Kallenberg","year":"1996","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"issue":"12","key":"10.1016\/j.preteyeres.2013.02.004_bib88","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib89","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3899\/jrheum.090980","article-title":"Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis","volume":"37","author":"Katchamart","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib90","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bjo.2009.171744","article-title":"Clinical features and visual outcomes of Japanese patients with scleritis","volume":"94","author":"Keino","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib93","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib95","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib96","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2007.133173","article-title":"Rituximab for treatment of ocular inflammatory disease: a series of four cases","volume":"93","author":"Kurz","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib97","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.survophthal.2006.02.011","article-title":"Scleritis","volume":"51","author":"Lin","year":"2006","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib99","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","article-title":"Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis","volume":"145","author":"Lin","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib100","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1167\/iovs.09-4322","article-title":"Inhibition of matrix metalloproteinase activity in the chick sclera and its effect on myopia development","volume":"51","author":"Liu","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib101","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis","volume":"308","author":"Lopez-Olivo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfn430","article-title":"Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients","volume":"24","author":"Lovric","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib103","first-page":"23","article-title":"Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis","volume":"9","author":"Marcellin","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bjo.79.1.57","article-title":"Human scleral elastic system: an immunoelectron microscopic study","volume":"79","author":"Marshall","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.1987.01060060079037","article-title":"Intravenous pulse methylprednisolone in scleritis","volume":"105","author":"McCluskey","year":"1987","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib106","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1442-9071.1988.tb01206.x","article-title":"Current concepts in the management of scleritis","volume":"16","author":"McCluskey","year":"1988","journal-title":"Aust. N. Z. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","article-title":"Prediction of response to treatment in patients with scleritis using a standardised scoring system","volume":"19","author":"McCluskey","year":"1991","journal-title":"Aust. N. Z. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-9071.1985.tb00416.x","article-title":"Scleritis and the spectrum of external inflammatory eye disease","volume":"13","author":"McCluskey","year":"1985","journal-title":"Aust. N. Z. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib109","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib110","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib111","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib112","doi-asserted-by":"crossref","first-page":"250","DOI":"10.7861\/clinmedicine.4-3-250","article-title":"The eye in systemic vasculitis","volume":"4","author":"Menezo","year":"2004","journal-title":"Clin. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/14737167.2.4.313","article-title":"Indirect medical costs in the first 3 years of rheumatoid arthritis: comparison of current methodological approaches","volume":"2","author":"Merkesdal","year":"2002","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib114","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.preteyeres.2013.02.004_bib115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcjo.2011.06.009","article-title":"Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases","volume":"11","author":"Miserocchi","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1477-7525-4-97","article-title":"Quality of life in age-related macular degeneration: a review of the literature","volume":"4","author":"Mitchell","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/ard.58.4.237","article-title":"Monocyte activation in patients with Wegener's granulomatosis","volume":"58","author":"Muller Kobold","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib118","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib119","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/09273940490912344","article-title":"Anterior scleritis, scleral thinning, and intraocular pressure measurement","volume":"13","author":"Nessim","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/clin.1996.4294","article-title":"Immune complex mediated vasculitis in hepatitis B and C infections and the effect of antiviral therapy","volume":"82","author":"Nityanand","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib121","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.76.1.17","article-title":"Surgically induced necrotising sclerokeratitis (SINS) \u2013 precipitating factors and response to treatment","volume":"76","author":"O'Donoghue","year":"1992","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib122","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib123","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/09273940802331643","article-title":"Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis","volume":"16","author":"Onal","year":"2008","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib124","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajo.2010.03.013","article-title":"Sub-tenon triamcinolone acetonide injection in the treatment of scleritis","volume":"150","author":"Park","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1523-1755.2004.00364.x","article-title":"Proteinase 3 sidesteps caspases and cleaves p21(Waf1\/Cip1\/Sdi1) to induce endothelial cell apoptosis","volume":"65","author":"Pendergraft","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib127","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib128","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.autrev.2011.04.028","article-title":"Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature","volume":"10","author":"Pons-Estel","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/ICU.0b013e32833f1060","article-title":"An update on the cause and treatment of scleritis","volume":"21","author":"Rachitskaya","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib131","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","article-title":"Scleritis and systemic disease association in a community-based referral practice","volume":"148","author":"Raiji","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib132","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0377-4929.64336","article-title":"Prevalence of bacterial pathogens causing ocular infections in South India","volume":"53","author":"Ramesh","year":"2010","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib133","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0161-6420(85)33822-8","article-title":"Necrotizing scleritis. A clinico-pathologic study of 41 cases","volume":"92","author":"Rao","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib134","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib136","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis?","volume":"87","author":"Reddy","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib137","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10067-009-1368-8","article-title":"Successful treatment of severe nodular scleritis with adalimumab","volume":"29","author":"Restrepo","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib189","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2009.164962","article-title":"Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis","volume":"94","author":"Roufas","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib138","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.4049\/jimmunol.0904068","article-title":"Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function","volume":"184","author":"Sabeh","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib139","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0161-6420(97)30361-3","article-title":"Scleritis-associated uveitis","volume":"104","author":"Sainz de la Maza","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","article-title":"Scleritis therapy","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib141","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib142","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archopht.116.11.1476","article-title":"Leukocyte adhesion molecule expression in scleritis","volume":"116","author":"Sangwan","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib143","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/j.1523-1755.2004.00640.x","article-title":"Membrane proteinase 3 expression and ANCA-induced neutrophil activation","volume":"65","author":"Schreiber","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib144","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib145","doi-asserted-by":"crossref","first-page":"e3709","DOI":"10.1371\/journal.pone.0003709","article-title":"Human sclera maintains common characteristics with cartilage throughout evolution","volume":"3","author":"Seko","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib146","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib147","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/bjo.2004.052738","article-title":"Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis","volume":"89","author":"Sen","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib148","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","article-title":"Infliximab for the treatment of active scleritis","volume":"44","author":"Sen","year":"2009","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib149","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2010.08.027","article-title":"A\u00a0standardized grading system for scleritis","volume":"118","author":"Sen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000090010","article-title":"Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis","volume":"38","author":"Seo","year":"2006","journal-title":"Ophthalmic Res."},{"issue":"Suppl. 2","key":"10.1016\/j.preteyeres.2013.02.004_bib151","first-page":"ii55","article-title":"B\u00a0cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience","volume":"62","author":"Shaw","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib152","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/archopht.125.7.895","article-title":"Infliximab therapy for the treatment of refractory ocular inflammatory disease","volume":"125","author":"Sobrin","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib153","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis","volume":"118","author":"Sohn","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","article-title":"Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab","volume":"45","author":"Stasi","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib156","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib157","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/eye.2010.68","article-title":"Bilateral disc swelling associated with posterior scleritis","volume":"24","author":"Stead","year":"2010","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib158","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib159","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib161","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2006.03.007","article-title":"Malignancies and soluble tumor antigens in rheumatic diseases","volume":"6","author":"Szekanecz","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib162","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000314634","article-title":"Malignancies in autoimmune rheumatic diseases \u2013 a mini-review","volume":"57","author":"Szekanecz","year":"2011","journal-title":"Gerontology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib163","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09273940600659393","article-title":"Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature","volume":"14","author":"Taban","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib164","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T\u00a0cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib165","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24454","article-title":"Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis","volume":"60","author":"Taylor","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib166","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.4049\/jimmunol.165.4.1863","article-title":"Oligosaccharides of hyaluronan are potent activators of dendritic cells","volume":"165","author":"Termeer","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib167","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","article-title":"Mycophenolate mofetil therapy for inflammatory eye disease","volume":"112","author":"Thorne","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib168","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1755-3768.1990.tb01926.x","article-title":"Regional glycosaminoglycans composition of the human sclera","volume":"68","author":"Trier","year":"1990","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib169","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/112067210701700320","article-title":"Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study","volume":"17","author":"Ueno","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.2007.126425","article-title":"Immunopathology of necrotising scleritis","volume":"92","author":"Usui","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib171","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.73.9.743","article-title":"Cyclosporin therapy for severe scleritis","volume":"73","author":"Wakefield","year":"1989","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib172","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archopht.1986.01050180081035","article-title":"Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease","volume":"104","author":"Wakefield","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib173","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrrheum.2011.41","article-title":"Autoimmunity: the role of neutrophils in SLE: untangling the NET","volume":"7","author":"Warde","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib174","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","article-title":"Ocular disease in patients with ANCA-positive vasculitis","volume":"3","author":"Watkins","year":"2010","journal-title":"J.\u00a0Ocul. Biol. Dis. Inform."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib176","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0014-4835(03)00212-4","article-title":"Scleral structure, organisation and disease. A review","volume":"78","author":"Watson","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib177","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib178","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00417-007-0634-1","article-title":"Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy","volume":"245","author":"Weiss","year":"2007","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib179","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0002-9394(81)90001-5","article-title":"Histopathologic and clinical associations of scleritis and glaucoma","volume":"91","author":"Wilhelmus","year":"1981","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.2009.04036.x","article-title":"Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus","volume":"159","author":"Wong","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib181","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib182","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjo.2009.171264","article-title":"Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha\/beta+CD3+CD4\u2212CD8\u2212 double-negative T cells","volume":"94","author":"Yeh","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib183","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/1529-0131(199906)42:6<1209::AID-ANR18>3.0.CO;2-M","article-title":"An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline","volume":"42","author":"Yelin","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib184","first-page":"199","article-title":"Ultrastructural studies of corneal collagen during the development of experimental scleritis in rabbits","volume":"4","author":"Young","year":"1981","journal-title":"Diagn. Histopathol"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib185","first-page":"508","article-title":"Identification of genes expressed in a human scleral cDNA library","volume":"9","author":"Young","year":"2003","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib186","first-page":"163","article-title":"Microarray analysis of gene expression in human donor sclera","volume":"10","author":"Young","year":"2004","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2013.02.004_bib188","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0161-6420(01)01018-1","article-title":"A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis","volume":"109","author":"Zamir","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2013.02.004_bib187","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1167\/iovs.05-0759","article-title":"Differential gene expression in mouse sclera during ocular development","volume":"47","author":"Zhou","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946213000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946213000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T09:02:12Z","timestamp":1644397332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946213000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":186,"alternative-id":["S1350946213000189"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2013.02.004","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}